跳至主要内容
临床试验/CTRI/2008/091/000215
CTRI/2008/091/000215尚未招募4 期

A prospective , randomized controlled trial comparing the efficacy of intravenous cyclophosphamide and alternate day prednisolone versus tacrolimus and alternate day prednisolone for induction of remission in patients with steroid resistant nephrotic syndrome

il0 个研究点目标入组 130 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed patients with idiopathic steroid resistant nephrotic syndrome
  • (initial or late resistance), 1 to 16 years old , shall be studied . Standard definitions will be used for defining the course of nephrotic syndrome

排除标准

  • Patients with impaired renal functions (GFR<60ml/mt/sqm , serum creatinine > 1.2 mg/dl or urea > 45 mg/dl, confirmed once over a period of 2 weeks).
  • Patients who have received immunosuppressive medications, other than oral prednisolone, in the preceding 6 months.
  • Patients staying more than 200 km from the Institute or those who not willing to come for monthly visits.

研究者

发起方
il

相似试验